Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Centeno-Schultz Clinic is a premier medical facility specializing in interventional orthopedics and regenerative medicine. Founded in 2005 by Dr. Christopher Centeno and Dr. John Schultz, the clinic is globally recognized for pioneering the use of bone marrow-derived stem cells and platelet-rich plasma (PRP) to treat musculoskeletal conditions. It serves as the headquarters and research hub for the Regenexx network, which standardizes advanced orthobiologic procedures globally. The clinic focuses on providing non-surgical alternatives for patients with joint pain, spine injuries, and sports-related trauma through precise, image-guided injections. Their extensive body of published research and proprietary cell-processing protocols support the efficacy of their treatments in orthopedic care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on The Centeno Clinic.